SERPINC1 and septic shock: Although initial trials with the IV infusion to restore plasma ATIII levels were promising, larger studies did not provide any benefit for overall mortality, and consequently, Rhodes et al. have made specific recommendations against the use of ATIII in the updated International Guidelines for the Management of Sepsis and Septic Shock [40,41].